The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The role of Epstein–Barr virus in epithelial malignancies
Open accessAbstract
The close association of Epstein–Barr virus (EBV) infection with non‐keratinizing nasopharyngeal carcinomas and a subset of gastric carcinomas suggests that EBV infection is a crucial event in these cancers. The difficulties encountered in infecting and transforming primary epithelial cells in experimental systems suggest that the role of EBV in epithelial malignancies is complex and multifactorial in nature. Genetic alterations in the premalignant epithelium may support the establishment of latent EBV infection, which is believed to be an initiation event. Oncogenic properties have been reported in multiple EBV latent genes. The BamH1 A rightwards transcripts (BART s) and the BART‐encoded microRNAs (miR‐BART s) are highly expressed in EBV‐associated epithelial malignancies and may induce malignant transformation. However, enhanced proliferation may not be the crucial function of EBV infection in epithelial malignancies, at least in the early stages of cancer development. EBV‐encoded gene products may confer anti‐apoptotic properties and promote the survival of infected premalignant epithelial cells harbouring genetic alterations. Multiple EBV‐encoded microRNAs have been reported to have immune evasion functions. Genetic alterations in host cells, as well as inflammatory stroma, could modulate the expression of EBV genes and alter the growth properties of infected premalignant epithelial cells, encouraging their selection during carcinogenesis. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Wang, K., Yuen, S. T., Xu, J., Lee, S. P., Yan, H. H. N., Shi, S. T., Siu, H. C., Deng, S., Chu, K. M., Law, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2983 · Cited by 1,045
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
Raab-Traub, N., & Flynn, K. (1986) · Cell · doi:10.1016/0092-8674(86)90803-2 · Cited by 912
Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., & Raab-Traub, N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331103 · Cited by 620
Focus on nasopharyngeal carcinoma
Lo, K. W., To, K. F., & Huang, D. P. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00119-9 · Cited by 559
Self-citationEpstein-Barr virus-associated gastric adenocarcinoma
Danilova, N. V., Malkov, P. G., Oleynikova, N. A., & Mikhailov, I. A. (2019) · Arkhiv patologii · doi:10.17116/patol20198103174 · Cited by 516
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
Borza, C. M., & Hutt-Fletcher, L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-594 · Cited by 484
Epstein-Barr virus-associated gastric adenocarcinoma.
Shibata, D. K., & Weiss, L. M. (1992) · PubMed · Cited by 474
Nachmani, D., Stern-Ginossar, N., Sarid, R., & Mandelboim, O. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.003 · Cited by 470
An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival
Choy, E. Y.-W., Siu, K.-L., Kok, K.-H., Lung, R. W.-M., Tsang, C. M., To, K.-F., Kwong, D. L.-W., Tsao, S. W., & Jin, D.-Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072581 · Cited by 462
Self-citationEpstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Cohen, J. I., Fauci, A. S., Varmus, H., & Nabel, G. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002878 · Cited by 381
The genomic landscape of nasopharyngeal carcinoma
Lin, D.-C., Meng, X., Hazawa, M., Nagata, Y., Varela, A. M., Xu, L., Sato, Y., Liu, L.-Z., Ding, L.-W., Sharma, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3006 · Cited by 366
Modulation of LMP1 protein expression by EBV-encoded microRNAs
Lo, A. K. F., To, K. F., Lo, K. W., Lung, R. W. M., Hui, J. W. Y., Liao, G., & Hayward, S. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702896104 · Cited by 356
Self-citationDawson, C. W., Port, R. J., & Young, L. S. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.004 · Cited by 355
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5
Barth, S., Pfuhl, T., Mamiani, A., Ehses, C., Roemer, K., Kremmer, E., Jaker, C., Hock, J., Meister, G., & Grasser, F. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1080 · Cited by 351
Song, L.-B., Zeng, M.-S., Liao, W.-T., Zhang, L., Mo, H.-Y., Liu, W.-L., Shao, J.-Y., Wu, Q.-L., Li, M.-Z., Xia, Y.-F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0094 · Cited by 329
Hutt-Fletcher, L. M. (2007) · Journal of Virology · doi:10.1128/jvi.00445-07 · Cited by 323
Shibata, D. K., Tokunaga, M., Uemura, Y., Sato, E., Tanaka, S., & Weiss, L. M. (1991) · PubMed · Cited by 317
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Regulation of the latent-lytic switch in Epstein–Barr virus
Kenney, S. C., & Mertz, J. E. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.002 · Cited by 281
Scholle, F., Bendt, K. M., & Raab-Traub, N. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10681-10689.2000 · Cited by 277
Epstein–Barr virus RNA confers resistance to interferon‐α‐induced apoptosis in Burkitt's lymphoma
Nanbo, A., Inoue, K., Adachi‐Takasawa, K., & Takada, K. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.954 · Cited by 276
The pathogenesis of Epstein–Barr virus persistent infection
Thorley-Lawson, D. A., Hawkins, J. B., Tracy, S. I., & Shapiro, M. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.04.005 · Cited by 254
Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling
Tsai, C.-L., Li, H.-P., Lu, Y.-J., Hsueh, C., Liang, Y., Chen, C.-L., Tsao, S. W., Tse, K.-P., Yu, J.-S., & Chang, Y.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2194 · Cited by 245
Self-citationIdentification of Novel Epstein-Barr Virus MicroRNA Genes from Nasopharyngeal Carcinomas
Zhu, J. Y., Pfuhl, T., Motsch, N., Barth, S., Nicholls, J., Grässer, F., & Meister, G. (2009) · Journal of Virology · doi:10.1128/jvi.01689-08 · Cited by 240
Miller, W. E., Earp, H. S., & Raab-Traub, N. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4390-4398.1995 · Cited by 237
Tsai, M., Raykova, A., Klinke, O. K., Bernhardt, K., Gärtner, K., Leung, C. S. K., Geletneky, K., Sertel, S., Münz, C., Feederle, R., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.012 · Cited by 232
The Epstein–Barr virus and the pathogenesis of lymphoma
Vockerodt, M., Yap, L., Shannon‐Lowe, C., Curley, H., Wei, W., Vrzalikova, K., & Murray, P. G. (2015) · The Journal of Pathology · doi:10.1002/path.4459 · Cited by 230
Young, L. S., Lau, R., Rowe, M., Niedobitek, G., Packham, G., Shanahan, F., Rowe, D. T., Greenspan, D., Greenspan, J. S., & Rickinson, A. B. (1991) · Journal of Virology · doi:10.1128/jvi.65.6.2868-2874.1991 · Cited by 226
Lo, K.-W., Chung, G. T.-Y., & To, K.-F. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.011 · Cited by 220
Self-citationModulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22
Lung, R. W.-M., Tong, J. H.-M., Sung, Y.-M., Leung, P.-S., Ng, D. C.-H., Chau, S.-L., Chan, A. W.-H., Ng, E. K.-O., Lo, K.-W., & To, K.-F. (2009) · Neoplasia · doi:10.1593/neo.09888 · Cited by 212
Self-citationHorikawa, T., Yang, J., Kondo, S., Yoshizaki, T., Joab, I., Furukawa, M., & Pagano, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3933 · Cited by 211
Dölken, L., Malterer, G., Erhard, F., Kothe, S., Friedel, C. C., Suffert, G., Marcinowski, L., Motsch, N., Barth, S., Beitzinger, M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.03.008 · Cited by 208
The significance of LMP1 expression in nasopharyngeal carcinoma
Tsao, S. W., Tramoutanis, G., Dawson, C. W., Lo, A. K. F., & Huang, D. P. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x02000901 · Cited by 204
Self-citationEpstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1α
Wakisaka, N., Kondo, S., Yoshizaki, T., Murono, S., Furukawa, M., & Pagano, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5223-5234.2004 · Cited by 204
Kong, Q.-L., Hu, L.-J., Cao, J.-Y., Huang, Y.-J., Xu, L.-H., Liang, Y., Xiong, D., Guan, S., Guo, B.-H., Mai, H.-Q., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000940 · Cited by 199
Crook, T., Nicholls, J. M., Brooks, L., O'Nions, J., & Allday, M. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203656 · Cited by 194
The Epstein–Barr Virus BART microRNAs target the pro-apoptotic protein Bim
Marquitz, A. R., Mathur, A., Nam, C. S., & Raab-Traub, N. (2011) · Virology · doi:10.1016/j.virol.2011.01.028 · Cited by 194
Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinoma
Lu, Q., Elia, G., Lucas, S., & Alero Thomas, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530107 · Cited by 194
Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing
Chen, S.-J., Chen, G.-H., Chen, Y.-H., Liu, C.-Y., Chang, K.-P., Chang, Y.-S., & Chen, H.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012745 · Cited by 185
Co-infections, inflammation and oncogenesis: Future directions for EBV research
Rickinson, A. B. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.004 · Cited by 184
Epstein–Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling
Samanta, M., Iwakiri, D., & Takada, K. (2008) · Oncogene · doi:10.1038/onc.2008.75 · Cited by 164
Sivachandran, N., Sarkari, F., & Frappier, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000170 · Cited by 162
Strong, M. J., Xu, G., Coco, J., Baribault, C., Vinay, D. S., Lacey, M. R., Strong, A. L., Lehman, T. A., Seddon, M. B., Lin, Z. N., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003341 · Cited by 160
Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
Tsang, C. M., Yip, Y. L., Lo, K. W., Deng, W., To, K. F., Hau, P. M., Lau, V. M. Y., Takada, K., Lui, V. W. Y., Lung, M. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202637109 · Cited by 159
Self-citationWood, V. H. J., O’Neil, J. D., Wei, W., Stewart, S. E., Dawson, W. O., & Young, L. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210496 · Cited by 144
A Novel Persistence Associated EBV miRNA Expression Profile Is Disrupted in Neoplasia
Qiu, J. J., Cosmopoulos, K., Pegtel, D. M., Hopmans, E. S., Murray, P. G., Middeldorp, J. M., Shapiro, M., & Thorley‐Lawson, D. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002193 · Cited by 141
Houalı, K., Wang, X., Shimizu, Y., Djennaoui, D., Nicholls, J. M., Fiorini, S., Bouguermouh, A., & Ooka, T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2945 · Cited by 141
Constitutive activation of distinct NF‐κB signals in EBV ‐associated nasopharyngeal carcinoma
Chung, G. T., Lou, W. P.-K., Chow, C., To, K., Choy, K. W., Leung, A. W.-C., Tong, C. Y., Yuen, J. W.-F., Ko, C., Yip, T. T., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4239 · Cited by 140
Self-citationLiu, P., Fang, X., Feng, Z., Guo, Y., Peng, R., Liu, T., Huang, Z., Feng, Y., Sun, X., Xiong, Z., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00823-11 · Cited by 125
MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1
Jung, Y., Choi, H., Kim, H., & Lee, S. K. (2014) · Journal of Virology · doi:10.1128/jvi.00721-14 · Cited by 124
Modulation of the Cell Growth Regulator mTOR by Epstein-Barr Virus-Encoded LMP2A
Moody, C. A., Scott, R. S., Amirghahari, N., Nathan, C. O., Young, L. S., Dawson, C., & Sixbey, J. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5499-5506.2005 · Cited by 123
Fukuda, M., & Longnecker, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1697-1705.2004 · Cited by 121
Kwok, H., Wu, C., Palser, A. L., Kellam, P., Sham, P. C., Kwong, D. L. �., & Chiang, A. (2014) · Journal of Virology · doi:10.1128/jvi.01665-14 · Cited by 118
The role of miRNAs and EBV BARTs in NPC
Marquitz, A. R., & Raab‐Traub, N. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.001 · Cited by 115
Hui, A. B., Or, Y. Y., Takano, H., Tsang, R. K., To, K., Guan, X., Sham, J. S., Hung, K., Lam, C. N. Y., van Hasselt, C. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0648 · Cited by 115
Self-citationFukuda, M., & Longnecker, R. (2007) · Journal of Virology · doi:10.1128/jvi.00537-07 · Cited by 112
Kondo, S., Wakisaka, N., Muramatsu, M., Zen, Y., Endo, K., Murono, S., Sugimoto, H., Yamaoka, S., Pagano, J. S., & Yoshizaki, T. (2011) · Journal of Virology · doi:10.1128/jvi.00188-11 · Cited by 107
Pegtel, D. M., Subramanian, A., Sheen, T., Tsai, C.-H. A., Golub, T. R., & Thorley‐Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15430-15442.2005 · Cited by 105
Hsu, C., Yi, Y.-H., Chang, K., Chang, Y., Chen, S., & Chen, H. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003974 · Cited by 103
Fang, C., Lee, C., Wu, C., Chang, Y., Yu, S., Chou, S., Huang, P., Chen, C., Hou, J., Chang, Y., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24179 · Cited by 103
Morrison, J. A., & Raab‐Traub, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2375-2382.2005 · Cited by 97
Lu, J., Lin, W. H., Chen, S.-Y., Longnecker, R., Tsai, S.-C., Chen, C.-L., & Tsai, C.-H. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507305200 · Cited by 96
Role of EBNA1 in NPC tumourigenesis
Frappier, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.002 · Cited by 95
Dutton, A., Woodman, C. B. J., Chukwuma, M. B., Last, J. I. K., Wei, W., Vockerodt, M., Baumforth, K. R. N., Flavell, J. R., Rowe, M., Taylor, A. M. R., et al. (2006) · Blood · doi:10.1182/blood-2006-05-020545 · Cited by 94
Kwok, H. F., Tong, A. H. Y., Lin, C. H., Lok, S., Farrell, P. J., Kwong, D. L. �., & Chiang, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036939 · Cited by 93
Zhang, G., Tsang, C. M., Deng, W., Yip, Y. L., Lui, V. W. Y., Wong, S. C. C., Cheung, A. L. M., Hau, P. M., Zeng, M., Lung, M. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062284 · Cited by 93
Self-citationTsang, C. M., Zhang, G., Seto, E., Takada, K., Deng, W., Yip, Y. L., Man, C., Hau, P. M., Chen, H., Cao, Y., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25173 · Cited by 92
Self-citationCD44+ Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma
Lun, S. W., Cheung, S., Cheung, P. F. Y., To, K., Woo, J. K. S., Choy, K. W., Chow, C., Cheung, C. C., Chung, G. T., Cheng, A. S.-H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052426 · Cited by 82
Self-citationCao, J. Y., Mansouri, S., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05648-11 · Cited by 81
Malignant transformation of B lymphoma cell line BJAB by Epstein–Barr virus‐encoded small RNAs
Yamamoto, N., Takizawa, T., Iwanaga, Y., Shimizu, N., & Yamamoto, N. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02145-1 · Cited by 79
Lo, A. K., Lo, K. W., Ko, C., Young, L. S., & Dawson, W. O. (2013) · The Journal of Pathology · doi:10.1002/path.4201 · Cited by 74
Self-citationNanbo, A., Yoshiyama, H., & Takada, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12280-12285.2005 · Cited by 74
Efficient Immortalization of Primary Nasopharyngeal Epithelial Cells for EBV Infection Study
Yip, Y. L., Pang, P. S., Deng, W., Tsang, C. M., Zeng, M., Hau, P. M., Man, C., Jin, Y., Yuen, A. P. W., & Tsao, S. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078395 · Cited by 71
Self-citationBamHI‐A rightward frame 1, an Epstein–Barr virus‐encoded oncogene and immune modulator
Hoebe, E. K., Large, T. Y. S. L., Greijer, A. E., & Middeldorp, J. M. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1758 · Cited by 53
Daskalogianni, C., Pyndiah, S., Apcher, S., Mazars, A., Manoury, B., Ammari, N., Nylander, K., Voisset, C., Blondel, M., & Fåhræus, R. (2014) · The Journal of Pathology · doi:10.1002/path.4431 · Cited by 48
Jiang, R., Cabras, G., Sheng, W., Zeng, Y., & Ooka, T. (2009) · Neoplasia · doi:10.1593/neo.09706 · Cited by 41
Benders, A. A., Tang, W., Middeldorp, J. M., et al. (2009) · Head and Neck Pathology · doi:10.1007/s12105-009-0148-8 · Cited by 25
Cited by
Epstein–Barr virus: more than 50 years old and still providing surprises
Young, L. S., Yap, L. F., & Murray, P. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.92 · Cited by 856
Epstein–Barr virus infection and nasopharyngeal carcinoma
Tsao, S. W., Tsang, C. M., & Lo, K. W. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0270 · Cited by 606
Self-citationRETRACTED ARTICLE: Vasculogenic mimicry formation in EBV-associated epithelial malignancies
Xiang, T., Lin, Y.-X., Ma, W., Zhang, H.-J., Chen, K.-M., He, G.-P., Zhang, X., Xu, M., Feng, Q.-S., Chen, M.-Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07308-5 · Cited by 172
RetractedMcMiller, T. L., Besharati, S., Yarchoan, M., Zhu, Q., Ünsal-Kaçmaz, K., Xu, K., Lee, J., Bhaijee, F., Engle, L. L., Taube, J. M., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010201 · Cited by 16
Metadata
- Authors
- Tsao, S., Tsang, C. M., To, K., & Lo, K.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2014-12-11
- Volume
- 235
- Issue
- 2
- Pages
- 323-333
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W1581034919
- Cited by
- 337
- References
- 80
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.